Supplemental material
Future Oncology
Volume 20, 2024 - Issue 15
Open access
3,174
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI
Tony Mok1 Department of Clinical Oncology, State Key Laboratory of Translational Oncology & Chinese University of Hong Kong, Hong Kong, Hong Kong PRCCorrespondence[email protected]
https://orcid.org/0000-0002-8251-0551
, https://orcid.org/0000-0002-8251-0551
Pasi A Jänne2 Medical Oncology, Dana-Farber Cancer Institute, Boston, MA02215, USAhttps://orcid.org/0000-0002-7821-4928
, Makoto Nishio3 Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo135-8550, Japanhttps://orcid.org/0000-0003-4969-4165
, Silvia Novello4 Oncology Department at San Luigi Hospital in Orbassano, University of Turin, 10124Torino, Italyhttps://orcid.org/0000-0001-7653-9748
, Martin Reck5 Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungenClinic, 22927Grosshansdorf, Germanyhttps://orcid.org/0000-0002-5348-4462
, Conor Steuer6 Hematology & Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA30322, USAhttps://orcid.org/0000-0001-6528-6319
, Yi-Long Wu7 Lung Cancer Institute, Guangdong Province People’s Hospital, Guangzhou, 510317, Chinahttps://orcid.org/0000-0001-8734-2131
, Ronan Fougeray8 Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ07920, USAhttps://orcid.org/0000-0003-0323-1157
, Pang-Dian Fan8 Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ07920, USAhttps://orcid.org/0000-0002-7968-7516
, Jie Meng8 Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ07920, USAhttps://orcid.org/0000-0002-6439-7292
, David W Sternberg8 Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ07920, USAhttps://orcid.org/0000-0002-3925-1304
, Stephen Esker8 Oncology Clinical Development, Daiichi Sankyo Inc, Basking Ridge, NJ07920, USA
& Helena A Yu9 Department of Medicine, Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY10065, USAhttps://orcid.org/0000-0002-0377-9510
show all
Pages 969-980
|
Received 13 Jul 2023, Accepted 23 Oct 2023, Published online: 14 Dec 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.